Concepedia

Junji Furuse

JF

Statistics

Publications

268

Citations

24.4K

H-Index

70

Active since

1990

Affiliations

National Cancer Center Hospital East(Current)

Kyorin University

Kanagawa Prefectural Hospital Organization

Kanagawa Cancer Center

Aichi Cancer Center

Junji Furuse is an author at National Cancer Center Hospital East specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

1990–2025

268

Publications

268

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa, George Lau, Masatoshi Kudo et al. · NEJM Evidence · 2022 · 1.4K citations · Full text

, , +16

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text

, , +14

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 1K citations · Full text

, , +8

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

Takuji Okusaka, Kohei Nakachi, Akira Fukutomi et al. · British Journal of Cancer · 2010 · 752 citations · Full text

, , +9

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda et al. · Gut · 2019 · 723 citations · Full text

, , +17

1–5 of 268